Is the third generation EGFR TKIs the solution for making EGFR mutant NSCLC a curable disease?

Spremljeno u:
Bibliografski detalji
Izdano u:Transl Lung Cancer Res
Glavni autor: Hirsch, Fred R.
Format: Artigo
Jezik:Inglês
Izdano: Pioneer Bioscience Publishing Company 2014
Teme:
Editorial
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367675/
https://ncbi.nlm.nih.gov/pubmed/25806320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.11.07
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items